GRAND RAPIDS – The Million Dollars Raised From Investors Brings patient company Closer to market for a device designed to help nurses and other caregivers safely transport patients.
Mayo Clinic led the bridge funding round for Grand Rapids-based Patient, which has offices in Detroit, Traverse City and Scottsdale, Arizona. Among the investors who joined Mayo Clinic on the bridge tour, East Lansing is headquartered Red Cedar VenturesHeadquartered in Lansing Quantum Medical ConceptsDallas-based Hughes Ventures and Atlanta-based Bravos LLC.
The funding will support the company as it seeks federal regulatory approval this fall for SimPull, continues research and development for additional functionality, ramps up production and launches its product in the first half of 2023, said Ryan Peters, co-founder and chief operating officer.
“We’re on the launch pad and getting ready for takeoff,” Peters said. Maybes.
Use of technology licensed from spectrum health Born with an idea from a physician, the company developed SimPull as a way to prevent muscle or back strain and other injuries for nurses and caregivers, and to increase efficiency and eliminate waste from single-use air mattresses often deployed to transport patients. Instead of taking multiple people to move a patient from a bed to a stretcher, SimPull allows a single caregiver to do so.
For example, the device gently moves a patient from a hospital bed to a stretcher for transportation to a surgical procedure or a diagnostic test such as a medical exam.
The patient company is testing the device in hospitals in the United States, including with caregivers at Spectrum Health in Grand Rapids and in Lansing-based Sbarro Health System.
“Unfortunately, we have all seen firsthand how some colleagues have been infected while transporting patients. The good news is that this device automates that process while simplifying everyday operations,” said Tony Bailey, clinical innovation advisor at Sparrow Health, in an announcement for Patient Co’s. Finding the Bridge.”SimPull is truly a device designed for clinical caregivers by clinical providers.”
Federal regulations require a physician to lift no more than 35 pounds at a time. This means that it usually requires moving the patient laterally from several people, especially obese patients.
SimPull requires two doctors to operate under current guidelines, although it can be operated with one person. The device also takes only two minutes to use, to avoid delays in collecting staff. At a time when hospitals are chronically understaffed, The Patient Co. bills SimPull as helping tackle a growing problem.
“We live in the most difficult time in history to be bedside nurses. Everyone knows about the nursing shortage, and it seems like almost everyone we meet has been hurt or knows someone who has been injured in bed,” said co-founder and CEO Andrew Heuerman, usually while Transferring patients.” “Our only goal as a company is to support doctors by saying enough is enough. With their support, we will continue to reimagine how patients move, in all settings of care, and we are proud of the impact this is having.”
Based on testing on health systems that have used the device, as well as feedback from nurses at a trade show and from a large medical device company, The Patient Co. Tweaks the final SimPull design.
Peters said one change led to a battery design in the device to make it more portable, rather than relying on AC power. The company has also expanded the straps used in the device to help better transport obese patients.
“We’re in the market and we’re listening to physicians who provide that voice of the customer,” Peters said.
The patient company previously raised $1 million in 2021 to support the development of SimPull. The capital round attracted around ten investors including Spectrum Health, Red Cedar Ventures and Invest in Detroit VenturesAnd the MedTech Venturesand Quantum Medical Concepts, the early-stage investment fund that the Michigan Medical Association formed in 2017.
Peters said the company plans to raise capital with a Series A round of capital in 2023 following the launch of the product.